Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies

H Jiang, X Zhang, X Chen, P Aramsangtienchai… - Chemical …, 2018 - ACS Publications
Protein lipidation, including cysteine prenylation, N-terminal glycine myristoylation, cysteine
palmitoylation, and serine and lysine fatty acylation, occurs in many proteins in eukaryotic …

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches

JA Urbina - Acta tropica, 2010 - Elsevier
A critical review of the development of specific chemotherapeutic approaches for the
management of American Trypanosomiasis or Chagas disease is presented, including …

Visible-Light-Driven Alkyne Hydro-/Carbocarboxylation Using CO2 via Iridium/Cobalt Dual Catalysis for Divergent Heterocycle Synthesis

J Hou, A Ee, W Feng, JH Xu, Y Zhao… - Journal of the American …, 2018 - ACS Publications
We present herein the first visible-light-driven hydrocarboxylation as well as
carbocarboxylation of alkynes using CO2 via an iridium/cobalt dual catalysis. Such …

Recent advances in the synthetic and medicinal perspective of quinolones: A review

P Dhiman, N Arora, PV Thanikachalam, V Monga - Bioorganic Chemistry, 2019 - Elsevier
In the modern scenario, the quinolone scaffold has emerged as a very potent motif
considering its clinical significance. Quinolones possess wide range of pharmacological …

Trypanocidal drugs: mechanisms, resistance and new targets

SR Wilkinson, JM Kelly - Expert reviews in molecular medicine, 2009 - cambridge.org
The protozoan parasites Trypanosoma brucei and Trypanosoma cruzi are the causative
agents of African trypanosomiasis and Chagas disease, respectively. These are debilitating …

Ergosterol biosynthesis and drug development for Chagas disease

JA Urbina - Memorias do Instituto Oswaldo Cruz, 2009 - SciELO Brasil
This article presents an overview of the currently available drugs nifurtimox (NFX) and
benznidazole (BZN) used against Trypanosoma cruzi, the aetiological agent of Chagas …

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

I Ribeiro, AM Sevcsik, F Alves, G Diap… - PLoS neglected …, 2009 - journals.plos.org
Endemic throughout Latin America with a prevalence rate of approximately 1.4%, Chagas
disease (CD) is estimated to kill 14,000 people every year, which is more people in the …

Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB

BT Mott, RS Ferreira, A Simeonov… - Journal of medicinal …, 2010 - ACS Publications
Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas' disease and
African sleeping sickness, respectively. Both parasites rely on essential cysteine proteases …

Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi

BE Mansfield, HN Oltean, BG Oliver, SJ Hoot… - PLoS …, 2010 - journals.plos.org
Despite the wealth of knowledge regarding the mechanisms of action and the mechanisms
of resistance to azole antifungals, very little is known about how the azoles are imported into …

Quimioterapia da doença de Chagas: estado da arte e perspectivas no desenvolvimento de novos fármacos

LC Dias, MA Dessoy, JJN Silva, OH Thiemann… - Química …, 2009 - SciELO Brasil
Neglected diseases are a major global cause of illness, long-term disability and death.
Chagas' disease is a parasitic infection widely distributed throughout Latin America, with …